TSW
CAH icon

Thompson Siegel & Walmsley’s Cardinal Health CAH Stock Holding History

Thompson Siegel & Walmsley’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14
Closed -$1K – 664
2020
Q1 		$1K Sell
14
-641,209
-100% -$33.3M ﹤0.01% 638
2019
Q4 		$32.4M Sell
641,223
-534,933
-45% -$27.6M 0.5% 67
2019
Q3 		$55.5M Sell
1,176,156
-169,303
-13% -$7.73M 0.88% 45
2019
Q2 		$63.4M Buy
1,345,459
+3,866
+0.3% +$178K 0.91% 45
2019
Q1 		$64.6M Buy
1,341,593
+256,974
+24% +$12.9M 0.91% 51
2018
Q4 		$48.4M Sell
1,084,619
-574,619
-35% -$30M 0.76% 61
2018
Q3 		$89.6M Sell
1,659,238
-133,390
-7% -$6.83M 1.14% 24
2018
Q2 		$87.5M Buy
1,792,628
+503,461
+39% +$28.5M 1.13% 25
2018
Q1 		$80.8M Sell
1,289,167
-424,629
-25% -$29.1M 0.99% 34
2017
Q4 		$105M Buy
1,713,796
+264,271
+18% +$16.3M 1.25% 19
2017
Q3 		$97M Buy
1,449,525
+354,043
+32% +$25M 1.16% 20
2017
Q2 		$85.4M Buy
1,095,482
+10,756
+1% +$812K 1.01% 29
2017
Q1 		$88.5M Sell
1,084,726
-74,743
-6% -$5.88M 1.04% 25
2016
Q4 		$83.4M Buy
1,159,469
+482,082
+71% +$34.9M 1.09% 18
2016
Q3 		$52.6M Sell
677,387
-54,900
-7% -$4.44M 0.82% 30
2016
Q2 		$57.1M Buy
732,287
+248,070
+51% +$19.8M 0.9% 26
2016
Q1 		$39.7M Buy
484,217
+193,593
+67% +$15.7M 0.64% 50
2015
Q4 		$25.9M Buy
290,624
+38,371
+15% +$3.26M 0.47% 75
2015
Q3 		$19.4M Buy
252,253
+33,968
+16% +$2.84M 0.36% 97
2015
Q2 		$18.3M Buy
218,285
+58,339
+36% +$5.15M 0.32% 126
2015
Q1 		$14.4M Buy
159,946
+13,331
+9% +$1.15M 0.25% 163
2014
Q4 		$11.8M Sell
146,615
-20,090
-12% -$1.59M 0.23% 172
2014
Q3 		$12.5M Sell
166,705
-2,660
-2% -$194K 0.25% 162
2014
Q2 		$11.6M Buy
169,365
+86,512
+104% +$5.89M 0.23% 183
2014
Q1 		$5.8M Sell
82,853
-34,272
-29% -$2.38M 0.13% 231
2013
Q4 		$7.83M Sell
117,125
-74,348
-39% -$4.54M 0.18% 211
2013
Q3 		$9.98M Sell
191,473
-40,856
-18% -$2.08M 0.22% 191
2013
Q2 		$11M Buy
+232,329
New +$10.6M 0.24% 185

Other funds holding CAH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AIG
American International Group New York $2.93M AUM 12.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Thompson Siegel & Walmsley's CAH Position: Q2 2020 in Review

Thompson Siegel & Walmsley sold out of Cardinal Health (CAH) in Q2 2020, closing a stake of 14 shares — an estimated $1K sold.

Thompson Siegel & Walmsley first reported a position in CAH in Q2 2013 and held it in 28 quarters. The position peaked at $105M in Q4 2017. 766 funds tracked by Wall St. Rank hold CAH as of Q2 2020.

  • Thompson Siegel & Walmsley reported no remaining Cardinal Health position as of Q2 2020 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 14 Cardinal Health shares in Q2 2020, an estimated $1K.
  • Thompson Siegel & Walmsley first reported a position in Cardinal Health in Q2 2013 and held it in 28 quarters.
  • Thompson Siegel & Walmsley's Cardinal Health position peaked at $105M in Q4 2017.
  • 766 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2020, filed 11 Aug 2020.